Literature DB >> 2576417

The structural biology of CD2.

P Moingeon1, H C Chang, P H Sayre, L K Clayton, A Alcover, P Gardner, E L Reinherz.   

Abstract

The CD2 molecule is a 50-55KD transmembrane glycoprotein expressed on the vast majority of thymocytes and virtually all peripheral T lymphocytes. Its functions are two-fold: adhesion and activation. CD2 serves to facilitate conjugate formation between the T-lineage cell and its cognate partner via intermolecular interaction of CD2 and LFA-3 on the former and latter cells, respectively. Perturbation of the CD2 extracellular segment by certain combinations of anti-CD2 MAbs or LFA-3 and a single anti-CD2 MAb activate T-lineage function. These CD2-mediated activation events also synergize with signals mediated through the TCR to augment T-cell response. Based on microchemical analysis of immunoaffinity-purified human CD2 and cDNA and genomic cloning of mouse and human molecules, considerable structural information is now available. The mature surface human CD2 molecule consists of 327 amino acids: a 185 aa extracellular segment; a 25 aa hydrophobic transmembrane segment; and a 117 aa cytoplasmic domain rich in prolines and basic residues. The CD2 gene is comprised of five exons which span approximately 12 Kb on chromosome 1. A similar protein structure and gene exon organization is found for the mouse CD2 homologue. The CD2 adhesion domain is approximately 103 aa in length and is encoded by a single exon (exon 2). This domain is resistant to proteolysis, even though it lacks any intrachain disulfides and, like the entire extracellular segment protein expressed in a baculovirus system, binds to its cellular ligand, LFA-3. The latter occurs with a micromolar Kd. This relatively low affinity suggests that multivalent interactions among CD2 monomers on the T cells and individual LFA-3 structures on the cognate partner are important in enhancing the avidity of the T-cell interaction with its target or stimulator cell. The affinity of the CD2 extracellular segment for LFA-3 is not affected by truncations in the CD2 cytoplasmic domain, implying that ligand binding is not regulated by intracellular mechanisms. Given that CD2 mRNA expression and surface CD2 copy number are increased by more than one order of magnitude post-TCR stimulation, it is more likely that adhesion via CD2 is modulated by alteration in surface copy number. Analysis of early transduction events occurring via CD3-Ti (TCR) and CD2 including single channel Ca2+ patch-clamp recordings on living human T lymphocytes indicate a virtual identity of signals.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576417     DOI: 10.1111/j.1600-065x.1989.tb00544.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  41 in total

1.  CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.

Authors:  Elena V Tibaldi; Ravi Salgia; Ellis L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.

Authors:  A D Beyers; L L Spruyt; A F Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Functional relationship between high-affinity E receptor and CD2-11.3 epitope.

Authors:  E Kontny; A Ryzewska
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

4.  CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.

Authors:  P Moingeon; J L Lucich; D J McConkey; F Letourneur; B Malissen; J Kochan; H C Chang; H R Rodewald; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

6.  Peptidoglycan and lipoteichoic acid modify monocyte phenotype in human whole blood.

Authors:  P F Jørgensen; J E Wang; M Almlöf; C Thiemermann; S J Foster; R Solberg; A O Aasen
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

7.  B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.

Authors:  D M Sansom; A Wilson; M Boshell; J Lewis; N D Hall
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

8.  Expression of CD2 on porcine B lymphocytes.

Authors:  J Sinkora; Z Reháková; M Sinkora; B Cukrowska; H Tlaskalová-Hogenová; A T Bianchi; B De Geus
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 9.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

Review 10.  The role of costimulatory molecules in allergic disease and asthma.

Authors:  Vincent Lombardi; Abinav K Singh; Omid Akbari
Journal:  Int Arch Allergy Immunol       Date:  2009-09-29       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.